Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs-Reference-Cited by-同舟云学术

Treatment of gynecological malignancies: long-term follow-up of health-related quality of life and healthcare costs

Published:2019-05 Issue:7 Volume:8 Page:475-486
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:Journal of Comparative Effectiveness Research

Author:

Pynnä Kristiina¹,Vuorela Piia²,Aronen Pasi³,Sintonen Harri⁴,Vainiola Tarja³,Leminen Arto¹,Roine Risto P⁵,Räsänen Pirjo⁶

Affiliation:

1. Department of Obstetrics & Gynecology, University of Helsinki & Helsinki University Hospital, PO Box 140 FI-00029 HUS, Finland

2. University of Helsinki, Biomedicum, Haartmaninkatu 8, 00290 Helsinki, Finland

3. University of Helsinki & Helsinki University Hospital, Administration, PO Box 705 FI-00029 HUS, Finland

4. Department of Public Health, University of Helsinki, PO Box 41, FI-00014 University of Helsinki, Finland

5. University of Helsinki & Helsinki University Hospital, Administration, PO Box 705 FI-00029 HUS, Finland & University of Eastern Finland, Kuopio, Finland

6. External Evaluation Unit, University of Helsinki & Helsinki University Hospital, PO Box 440 FI-00029 HUS, Finland

Abstract

Aim: To assess long-term health-related quality of life (HRQoL) and treatment-related costs in gynecological cancer patients, and to compare HRQoL between cancer types and to age-standardized general female population. Materials & methods: A prospective 8–10-year follow-up of 218 patients treated in Helsinki University Hospital in 2002–2004. Results: The most common malignancies were uterine, ovarian and cervical cancers. The mean HRQoL scores were 0.880 (baseline), 0.885 (6 months) and 0.884 for survivors in the end of the study. Depression, vitality and sexual activity were impaired at baseline but improved during follow-up. Total secondary healthcare costs during the follow-up averaged EUR 41342. Conclusion: The long-term HRQoL of surviving gynecological cancer patients was good and similar to that of age-standardized general female population.

Publisher

Future Medicine Ltd

Subject

Health Policy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/cer-2018-0125

Reference46 articles.

1. The WHO International Agency for Research on Cancer (2018). www.iarc.fr/index.php.

2. Cancer Research UK (2018). www.cancerresearchuk.org/cancer-info/cancerstats/.

3. Centers for Disease Control and Prevention (2018). www.cdc.gov/cancer/gynecologic/index.htm.

4. Cancer Australia (2018). http://canceraustralia.gov.au/affected-cancer/cancer-types/gynaecological-cancers.

5. Syöpäjärjestöt Finnish Cancer Association (2018). www.cancer.fi/.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China;BMC Cancer;2021-10-16

2. Postoperative health-related quality of life of patients with gynecological malignancy: a meta-analysis;Supportive Care in Cancer;2021-02-17

3. Evaluation of the quality of life of ovarian cancer patients in the context of selected quantitative variables such as body mass, number of miscarriages and time from diagnosis;Family Medicine & Primary Care Review;2019